Wednesday, December 26, 2007

G.S.K. Velu

"Indigenisation of medical technology is the need of the hour to deliver the 'health for all' objective. The Government of India should incentivise and motivate Indian manufacturing initiatives to position India as a global hub for medical technology manufacturing."

Dr. G.S.K. Velu, Managing Director Trivitron Group of companies
December 28, over lunch

5 comments:

Murali said...

About Velu....

Dr. Velu holds office as the Managing Director of Trivitron group of companies on the healthcare and technology front. He is also the MD of Metropolis Health Services (I) Ltd, the President of AMDSI & Head of Manufacturing Sub Committee of ASSOCHAM and CII. Capitalizing on his vast experience of over 18 years in the diagnostics and healthcare industry Trivitron Group of Companies has grown to become Rs.110 Crore group in less than a decade.


Dr. Velu firmly believes that India not only has the potential to become a Holistic Healthcare destination for catering to the healthcare needs of world, but also provides an opportunity for indigenization through cost effective products of International quality. He believes that with conducive policies and right infrastructure India can address the needs of global markets subsequently and has been diligently working towards the same by making representations through platforms such as AMDSI, ASSOCHAM & CII.


A Ph D in Pharmacology, from IBAM, Kolkata, a graduate from Bits Pilani in Pharma and a master from LIBA, he is often called upon to represent India at various seminars/delegations worldwide to deliver presentations and lecture on the healthcare and clinical diagnostics industries.


He is also a proud recipient of some of the prestigious awards like Rajiv Gandhi Shiromani award – 2007 and The Entrepreneur of the Year award for 2006” by Modern Medicare. He is also the only person in the Healthcare Industry to receive “The ITM University Awards for Corporate Excellence for the year 2006”. He has also published scientific papers in ‘Journal of Interfacial & Colloidal sciences’, USA and ‘Journal of Biophysics and Biomedical sciences’, USA.


Prior to the inception of Trivitron, he was the Country Manager (India) of Ciba Corning Diagnostics/Chiron Diagnostics (presently Bayer Diagnostics) and subsequently became the Director, South Asia.

Murali said...

About Trivitron...

Trivitron is one of the top 10 Medical Technology companies in India and aims to bring in a revolution in manufacturing Industry. It operates in the field of Medical Equipment, Medical Devices, Clinical Diagnostic Equipment, Medical Consumables & disposables, Medical Software and Consultancy services. Since its inception in 1997, Trivitron has grown at a steady pace to become the largest Indian Medical Technology company operating out of India and has recorded an annual sales revenue of Rs.1.5 Billion (USD 37 Million) for year 2006-07.

Trivitron is only company in India to have the largest product offerings across various specialties. It specializes in a comprehensive range of medical device solutions covering the fields of imaging, cardiology, nephrology, critical care, orthopaedics, anaesthesiology, intensive care, obstetrics & gynaecology, radiology, urology, ophthalmology, gastroenterology, microbiology, biochemistry, haematology, immunology, molecular biology, blood banking, surgery, home care & geriatrics.

**
Source
Neha Damani
Consultant
Hanmer & Partners Communications
Old No 121/12, New No 275,
(Near Studio Cell), TTK Road,
Alwarpet, Chennai - 600 018.
Mobile: 9840246513
Tel: 044 - 42144892
Fax: 044 - 42144891
URL: www.hanmerpr.com

Murali said...

Also present at the interaction...

1) Sameer D. Saral, Deputy MD, Trivitron
2) M.Bharath Yeshwanth,pursuing final year B.E(ECE) in Rajarajeswari Engineering College,Chennai
3)J.Shriram,pursuing final year B.Tech(Mech) in NIT,Tiruchy
4) Kumar Shankar Roy, Pharma analyst, BL Research Bureau

Anonymous said...

Trivitron may be big company but their principles are small.They just told their employees to leave without fulfilling their settlement.neither given their DA and mobile allowances which they are due to pay.

Anonymous said...

Trivitron showing themselves a big Co. in Healthcare Industry but their principal is too much harmful for those candidates who are joining here to build their future. Specally, careerist person shouldn't choose this organization. Lot of differences between offering packages and real take home, without any reason they are deducting offered KRA Amount, deducting salary. They just forced their employees to leave this organization without settling DA, Telephone, Yearly Medical & LTA benefits and other expenses. This organization has a hope to reach target of INR 1000 crore within 2010 which is most EMOTIONAL DREAM of Trivitron. The Co. who is replacing utility staffs with low graded so frequently this dream is not for them. Also the present staff's confident and wishes of ex-employees are not with them.